封面
市场调查报告书
商品编码
1887629

全球医药玻璃包装市场

Pharmaceutical Glass Packaging

出版日期: | 出版商: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 英文 377 Pages | 商品交期: 最快1-2个工作天内

价格

本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

全球医药玻璃包装市场预计2030年将达到344亿美元

2024年全球医药玻璃包装市场规模估计为222亿美元,预计到2030年将达到344亿美元,在分析期间(2024-2030年)内复合年增长率(CAGR)为7.6%。本报告分析的细分市场之一-药瓶,预计复合年增长率为5.8%,到分析期末将达到105亿美元。管瓶细分市场预计在分析期间内复合年增长率为8.2%。

美国市场规模估计为65亿美元,而中国市场预计将以8.7%的复合年增长率成长。

预计到2024年,美国医药玻璃包装市场规模将达65亿美元。作为世界第二大经济体,中国市场预计到2030年将达到54亿美元,在2024年至2030年的分析期间内,年复合成长率(CAGR)将达到8.7%。其他值得关注的区域市场包括日本和加拿大,预计在分析期内,这两个市场的年复合成长率将分别达到6.5%和7.1%。在欧洲,德国的年复合成长率预计将达到约7.0%。

全球医药玻璃包装市场-主要市场趋势与驱动因素概述

为什么玻璃是药品包装的黄金标准?

玻璃包装因其卓越的阻隔性能、化学稳定性和透明性,长期以来在製药业备受推崇,成为确保药品安全性、纯度和有效性的首选材料。製药玻璃包装主要包括瓶子、管瓶、安瓿和注射器,用于储存各种药物,从简单的维生素补充剂到复杂的生物製药和疫苗。玻璃的惰性确保其不会与内容物发生反应,这对于易受其他物质污染或改变性质的敏感药物至关重要。此外,玻璃能够承受高温灭菌过程,使其成为维持许多製药应用所需无菌环境的关键材料。

玻璃包装技术的创新如何惠及製药业?

医药玻璃包装领域的持续创新致力于提升玻璃容器的安全性和功能性,同时最大限度地降低破损和污染等风险。其中一项关键进展是硼硅酸玻璃的研发,这种玻璃具有极高的抗热衝击和抗化学浸出性能,为关键药品提供了更安全的容器。此外,各公司也正在投资表面处理和涂层技术,以提高管瓶的耐用性和性能,并防止分层和颗粒产生等问题。这些技术进步不仅延长了药品的保质期,还透过减少材料废弃物和提高生产效率,助力产业转型为更永续的实践。

哪些趋势将塑造医药玻璃包装的未来?

在塑造医药玻璃包装未来发展的几个主流趋势中,生物技术的兴起和生物製药(包括疫苗和生物製药)的快速发展尤其关键。这些产品需要严格的包装规格以维持其分子结构的完整性,而这种转变正推动着市场对高品质、耐用且可客製化的玻璃包装解决方案的需求。此外,全球监管机构对医药包装日益严格的监管压力,旨在确保病患安全和产品质量,这迫使製药公司和玻璃包装製造商遵守更高的标准。同时,包装的永续性也日益受到重视,製药业正寻求透过更多可回收材料和更有效率的生产流程来减少其对环境的影响。

哪些因素推动了医药玻璃包装市场的成长?

医药玻璃包装市场的成长受多种因素驱动,包括生物製药需求的不断增长,以及对复杂、敏感药物配方(需要高品质包装解决方案)的需求。玻璃製造和加工技术的进步使製造商能够生产出更坚固、更安全的产品,满足製药业的严格要求。此外,监管机构对更安全可靠的包装解决方案的要求也促使製药业转向玻璃等可靠材料。消费行为也是关键驱动因素。消费者对药品安全性和品质的日益重视,使其更倾向于选择玻璃包装的药品,因为玻璃具有非反应性。全球医疗保健成本的上升以及新兴市场製药行业的扩张进一步扩大了对医药玻璃包装的需求,巩固了其在全球医疗产品供应中的关键作用。

部分:

产品类型(瓶装、管瓶、安瓿瓶装、药筒及注射器),药品类型(非专利、品牌名称、生物製药)

受访公司范例

  • Becton, Dickinson and Company
  • Corning, Inc.
  • Gerresheimer AG
  • Ardagh Group SA
  • Agrado SA
  • Beatson Clark PLC
  • Hindusthan National Glass &Industries Ltd.
  • Bormioli Pharma Spa
  • DWK Life Sciences LLC
  • Haldyn Glass Ltd.
  • ESSCO Glass
  • Dobbies Garden Centres Limited
  • Can Do Company Limited
  • As One Corporation
  • Dunelm(Soft Furnishings)Limited

人工智慧集成

我们正在利用检验的专家内容和人工智慧工具,改变您分析市场和竞争情报的方式。

Market Glass, Inc. 并没有采用查询LLM 或产业专用的SLM 的典型方法,而是建立了一个由世界各地领域专家精心策划的内容库,其中包括影片文字稿、部落格、搜寻引擎研究以及大量的公司、产品/服务和市场数据。

关税影响係数

在最新发布的报告中,Market Glass, Inc. 将关税对地理市场的影响纳入考量,并根据公司总部所在地、製造地以及进出口(成品和OEM产品)情况,预测企业竞争地位的变化。这种复杂多变的市场现实会从多个方面影响竞争对手,包括增加销货成本、降低盈利和重组供应链,同时也会影响微观和宏观市场动态。

目录

第一章调查方法

第二章执行摘要

  • 市场概览
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章 市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 西班牙
  • 俄罗斯
  • 其他欧洲
  • 亚太地区
  • 澳洲
  • 印度
  • 韩国
  • 亚太其他地区
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中东
  • 伊朗
  • 以色列
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 其他中东地区
  • 非洲

第四章 竞赛

简介目录
Product Code: MCP13956

Global Pharmaceutical Glass Packaging Market to Reach US$34.4 Billion by 2030

The global market for Pharmaceutical Glass Packaging estimated at US$22.2 Billion in the year 2024, is expected to reach US$34.4 Billion by 2030, growing at a CAGR of 7.6% over the analysis period 2024-2030. Bottles, one of the segments analyzed in the report, is expected to record a 5.8% CAGR and reach US$10.5 Billion by the end of the analysis period. Growth in the Vials segment is estimated at 8.2% CAGR over the analysis period.

The U.S. Market is Estimated at US$6.5 Billion While China is Forecast to Grow at 8.7% CAGR

The Pharmaceutical Glass Packaging market in the U.S. is estimated at US$6.5 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$5.4 Billion by the year 2030 trailing a CAGR of 8.7% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 6.5% and 7.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 7.0% CAGR.

Global Pharmaceutical Glass Packaging Market - Key Trends & Drivers Summarized

Why Is Glass the Gold Standard for Pharmaceutical Packaging?

Glass packaging has long been revered in the pharmaceutical industry for its exceptional barrier properties, chemical stability, and transparency, making it a preferred material for ensuring the safety, purity, and efficacy of pharmaceutical products. Pharmaceutical glass packaging primarily includes bottles, vials, ampoules, and syringes that are used to store everything from simple vitamins to complex biologics and vaccines. The inert nature of glass ensures that it does not react with the contents it holds, a critical requirement for sensitive medications that could be altered or contaminated by other materials. Additionally, glass's ability to withstand sterilization processes at high temperatures makes it indispensable for maintaining the sterile conditions required for many pharmaceutical applications.

How Are Innovations in Glass Packaging Benefiting the Pharmaceutical Industry?

The ongoing innovations in pharmaceutical glass packaging focus on enhancing the safety and functionality of glass containers while minimizing risks such as breakage and contamination. One of the key advancements has been the development of borosilicate glass, which is highly resistant to thermal shock and chemical leaching, thereby providing an even safer container for critical medications. Additionally, companies are investing in surface treatments and coating technologies that enhance the durability and performance of glass vials, preventing issues like delamination and particle generation. These technological advancements not only extend the shelf life of pharmaceutical products but also support the industry's shift towards more sustainable practices by reducing material waste and improving manufacturing efficiencies.

What Trends Are Shaping the Future of Pharmaceutical Glass Packaging?

Several prevailing trends are shaping the future of pharmaceutical glass packaging. The rise in biotechnology and the increasing development of biopharmaceuticals, including vaccines and biologics, which often require stringent packaging specifications to maintain molecular integrity, is a significant factor. This shift is driving demand for high-quality, durable, and customizable glass packaging solutions. Additionally, the global push towards stricter regulations on pharmaceutical packaging to ensure patient safety and product quality is prompting pharmaceutical companies and glass packaging manufacturers to adhere to higher standards. There is also a growing trend towards sustainability in packaging, with the pharmaceutical sector seeking ways to reduce its environmental footprint through more recyclable materials and efficient manufacturing processes.

What Factors Are Catalyzing the Growth of the Pharmaceutical Glass Packaging Market?

The growth in the pharmaceutical glass packaging market is driven by several factors, including the increasing demand for biologics and the need for complex and sensitive drug formulations that require high-quality packaging solutions. Technological advancements in glass production and treatment methods are enabling manufacturers to produce more robust and safer products, catering to the stringent requirements of the pharmaceutical industry. Moreover, regulatory requirements for safer and more secure packaging solutions are pushing the pharmaceutical sector towards more reliable materials like glass. Consumer behavior is also a significant driver; as the awareness of drug safety and quality increases, so does the preference for pharmaceutical products packaged in glass due to its non-reactive nature. The global increase in healthcare expenditures and the expansion of the pharmaceutical industry in emerging markets are further amplifying the demand for pharmaceutical glass packaging, ensuring its pivotal role in the delivery of healthcare products worldwide.

SCOPE OF STUDY:

The report analyzes the Pharmaceutical Glass Packaging market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product Type (Bottles, Vials, Ampoules, Cartridges & Syringes); Drug Type (Generic, Branded, Biologic)

Geographic Regions/Countries:

World; USA; Canada; Japan; China; Europe; France; Germany; Italy; UK; Spain; Russia; Rest of Europe; Asia-Pacific; Australia; India; South Korea; Rest of Asia-Pacific; Latin America; Argentina; Brazil; Mexico; Rest of Latin America; Middle East; Iran; Israel; Saudi Arabia; UAE; Rest of Middle East; Africa.

Select Competitors (Total 41 Featured) -

  • Becton, Dickinson and Company
  • Corning, Inc.
  • Gerresheimer AG
  • Ardagh Group SA
  • Agrado SA
  • Beatson Clark PLC
  • Hindusthan National Glass & Industries Ltd.
  • Bormioli Pharma S.p.a.
  • DWK Life Sciences LLC
  • Haldyn Glass Ltd.
  • ESSCO Glass
  • Dobbies Garden Centres Limited
  • Can Do Company Limited
  • As One Corporation
  • Dunelm (Soft Furnishings) Limited

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Trade Shocks, Uncertainty, and the Structural Rewiring of the Global Economy
    • How Trump's Tariffs Impact the Market? The Big Question on Everyone's Mind
    • Glass Packaging: Sustainable, Green, and Pure Form of Packaging
    • An Introduction to Pharmaceutical Glass Packaging
    • Types of Glass Containers Used for Packaging in Pharmaceutical Industry
    • Pharmaceutical Glass Packaging Product Types
    • Key Advantages & Disadvantages of Glass Containers
    • Global Market Prospects & Outlook
    • Glass Bottles: The Largest Product Type
    • Generic Drugs Represent the Largest Segment
    • Developed Regions Lead the Pharmaceutical Glass Packaging Market
    • Growth of Pharmaceutical Manufacturing in Developing Economies Supports Market
    • Competition
    • Recent Market Activity
    • Pharmaceutical Glass Packaging - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Strong Rise in Pharmaceutical Sales to Drive Demand for Glass Packaging Solutions
    • Global Prescription Drug Sales (In US$ Billion) for the Years 2017, 2019, 2021, 2023 & 2025
    • Rapid Growth of Generic Drugs Augurs Well for Glass Packaging Market
    • Global Generic Drugs Market Size (in $ Billion) for the Years 2016, 2019, 2020 & 2025
    • Increasing Significance of Biologic Drugs Fuels Innovations in Packaging and Delivery Techniques
    • Global Biologic Drugs Market Size (in US$ Billion) for the Years 2019, 2022 & 2025
    • Aging Population, Increasing Burden of Chronic Disease and Consequent Rise in Demand for Injectables Drugs Augurs Well for Glass Packaging
    • Global Aging Population Statistics for the 65+ Age Group in Million by Geographic Region for the Years 2019, 2025, 2035 and 2050
    • Global Cancer Incidence: Number of New Cancer Cases in Million for the Years 2018, 2020, 2025, 2030, 2035 and 2040
    • World Diabetes and Population Statistics (2019, 2030 & 2045)
    • Contract Packaging Trend Augurs Well for the Pharma Glass Packaging Market
    • Ampoules Emerge as a Preferred Packaging Option for Pharma Companies
    • Parenteral Packaging Market Drives Demand for Glass Vials & Ampoules
    • Silica Bottles Facilitate Targeted Drug Delivery
    • Innovative Glass Packaging Solutions Help Improve Quality of Drugs
    • Innovations & Advancements Drive Market Growth
    • SCHOTT Offers syriQ BioPure(R) and SCHOTT TOPPAC(R) Syringes
    • Corning Creates Boron-Free Valor(R) Glass
    • Recyclability and Sustainability Increases Commodity Value of Glass, Paving Way for Use in Pharma Sector
    • Impending Phase-out of Plastic Brings to Light the Importance of Glass for Pharmaceutical Packaging Companies
    • Glass Flakes: A Key Concern for the Pharmaceutical Glass Packaging Manufacturers
    • Aluminosilicate Glass Emerges as a Solution to the Issue of Glass Flakes
    • Product Recall Incidents Likely to Hamper Market Stability
    • Alternative Materials Present A Threat to Glass Packaging in Pharmaceutical Industry
    • High Cost of Glass Packaging Containers: A Major Market Restraint
    • Cost Breakdown for Container Glass by Components
    • Emphasis on Product Integrity Drives Need for Anti-Counterfeit Pharmaceutical Packaging
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Pharmaceutical Glass Packaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Pharmaceutical Glass Packaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 3: World 16-Year Perspective for Pharmaceutical Glass Packaging by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Bottles by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Bottles by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 6: World 16-Year Perspective for Bottles by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Vials by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Vials by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 9: World 16-Year Perspective for Vials by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Ampoules by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Ampoules by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 12: World 16-Year Perspective for Ampoules by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Cartridges & Syringes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Cartridges & Syringes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 15: World 16-Year Perspective for Cartridges & Syringes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Generic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Generic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 18: World 16-Year Perspective for Generic by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Branded by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Branded by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 21: World 16-Year Perspective for Branded by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Biologic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 23: World Historic Review for Biologic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 24: World 16-Year Perspective for Biologic by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 25: World Pharmaceutical Glass Packaging Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Pharmaceutical Glass Packaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • Pharmaceutical Packaging Market in the US: An Overview
    • US Pharmaceutical Packaging Market by Material (in %) for 2023
    • TABLE 26: USA Recent Past, Current & Future Analysis for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 28: USA 16-Year Perspective for Pharmaceutical Glass Packaging by Product Type - Percentage Breakdown of Value Sales for Bottles, Vials, Ampoules and Cartridges & Syringes for the Years 2014, 2025 & 2030
    • TABLE 29: USA Recent Past, Current & Future Analysis for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 31: USA 16-Year Perspective for Pharmaceutical Glass Packaging by Drug Type - Percentage Breakdown of Value Sales for Generic, Branded and Biologic for the Years 2014, 2025 & 2030
  • CANADA
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 34: Canada 16-Year Perspective for Pharmaceutical Glass Packaging by Product Type - Percentage Breakdown of Value Sales for Bottles, Vials, Ampoules and Cartridges & Syringes for the Years 2014, 2025 & 2030
    • TABLE 35: Canada Recent Past, Current & Future Analysis for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 37: Canada 16-Year Perspective for Pharmaceutical Glass Packaging by Drug Type - Percentage Breakdown of Value Sales for Generic, Branded and Biologic for the Years 2014, 2025 & 2030
  • JAPAN
    • Pharmaceutical Glass Packaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 40: Japan 16-Year Perspective for Pharmaceutical Glass Packaging by Product Type - Percentage Breakdown of Value Sales for Bottles, Vials, Ampoules and Cartridges & Syringes for the Years 2014, 2025 & 2030
    • TABLE 41: Japan Recent Past, Current & Future Analysis for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Japan Historic Review for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 43: Japan 16-Year Perspective for Pharmaceutical Glass Packaging by Drug Type - Percentage Breakdown of Value Sales for Generic, Branded and Biologic for the Years 2014, 2025 & 2030
  • CHINA
    • Pharmaceutical Glass Packaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • Market Overview
    • TABLE 44: China Recent Past, Current & Future Analysis for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 46: China 16-Year Perspective for Pharmaceutical Glass Packaging by Product Type - Percentage Breakdown of Value Sales for Bottles, Vials, Ampoules and Cartridges & Syringes for the Years 2014, 2025 & 2030
    • TABLE 47: China Recent Past, Current & Future Analysis for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: China Historic Review for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 49: China 16-Year Perspective for Pharmaceutical Glass Packaging by Drug Type - Percentage Breakdown of Value Sales for Generic, Branded and Biologic for the Years 2014, 2025 & 2030
  • EUROPE
    • Pharmaceutical Glass Packaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • Europe Pharmaceutical Packaging: A Prelude
    • Europe Pharmaceutical Packaging Materials Market by Application (in %) for 2023
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Pharmaceutical Glass Packaging by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Pharmaceutical Glass Packaging by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 52: Europe 16-Year Perspective for Pharmaceutical Glass Packaging by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 55: Europe 16-Year Perspective for Pharmaceutical Glass Packaging by Product Type - Percentage Breakdown of Value Sales for Bottles, Vials, Ampoules and Cartridges & Syringes for the Years 2014, 2025 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 58: Europe 16-Year Perspective for Pharmaceutical Glass Packaging by Drug Type - Percentage Breakdown of Value Sales for Generic, Branded and Biologic for the Years 2014, 2025 & 2030
  • FRANCE
    • Pharmaceutical Glass Packaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 59: France Recent Past, Current & Future Analysis for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 61: France 16-Year Perspective for Pharmaceutical Glass Packaging by Product Type - Percentage Breakdown of Value Sales for Bottles, Vials, Ampoules and Cartridges & Syringes for the Years 2014, 2025 & 2030
    • TABLE 62: France Recent Past, Current & Future Analysis for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: France Historic Review for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 64: France 16-Year Perspective for Pharmaceutical Glass Packaging by Drug Type - Percentage Breakdown of Value Sales for Generic, Branded and Biologic for the Years 2014, 2025 & 2030
  • GERMANY
    • Pharmaceutical Glass Packaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 67: Germany 16-Year Perspective for Pharmaceutical Glass Packaging by Product Type - Percentage Breakdown of Value Sales for Bottles, Vials, Ampoules and Cartridges & Syringes for the Years 2014, 2025 & 2030
    • TABLE 68: Germany Recent Past, Current & Future Analysis for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Germany Historic Review for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 70: Germany 16-Year Perspective for Pharmaceutical Glass Packaging by Drug Type - Percentage Breakdown of Value Sales for Generic, Branded and Biologic for the Years 2014, 2025 & 2030
  • ITALY
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 73: Italy 16-Year Perspective for Pharmaceutical Glass Packaging by Product Type - Percentage Breakdown of Value Sales for Bottles, Vials, Ampoules and Cartridges & Syringes for the Years 2014, 2025 & 2030
    • TABLE 74: Italy Recent Past, Current & Future Analysis for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Italy Historic Review for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 76: Italy 16-Year Perspective for Pharmaceutical Glass Packaging by Drug Type - Percentage Breakdown of Value Sales for Generic, Branded and Biologic for the Years 2014, 2025 & 2030
  • UNITED KINGDOM
    • Pharmaceutical Glass Packaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 77: UK Recent Past, Current & Future Analysis for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 79: UK 16-Year Perspective for Pharmaceutical Glass Packaging by Product Type - Percentage Breakdown of Value Sales for Bottles, Vials, Ampoules and Cartridges & Syringes for the Years 2014, 2025 & 2030
    • TABLE 80: UK Recent Past, Current & Future Analysis for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: UK Historic Review for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 82: UK 16-Year Perspective for Pharmaceutical Glass Packaging by Drug Type - Percentage Breakdown of Value Sales for Generic, Branded and Biologic for the Years 2014, 2025 & 2030
  • SPAIN
    • TABLE 83: Spain Recent Past, Current & Future Analysis for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Spain Historic Review for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 85: Spain 16-Year Perspective for Pharmaceutical Glass Packaging by Product Type - Percentage Breakdown of Value Sales for Bottles, Vials, Ampoules and Cartridges & Syringes for the Years 2014, 2025 & 2030
    • TABLE 86: Spain Recent Past, Current & Future Analysis for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Spain Historic Review for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 88: Spain 16-Year Perspective for Pharmaceutical Glass Packaging by Drug Type - Percentage Breakdown of Value Sales for Generic, Branded and Biologic for the Years 2014, 2025 & 2030
  • RUSSIA
    • TABLE 89: Russia Recent Past, Current & Future Analysis for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Russia Historic Review for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 91: Russia 16-Year Perspective for Pharmaceutical Glass Packaging by Product Type - Percentage Breakdown of Value Sales for Bottles, Vials, Ampoules and Cartridges & Syringes for the Years 2014, 2025 & 2030
    • TABLE 92: Russia Recent Past, Current & Future Analysis for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Russia Historic Review for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 94: Russia 16-Year Perspective for Pharmaceutical Glass Packaging by Drug Type - Percentage Breakdown of Value Sales for Generic, Branded and Biologic for the Years 2014, 2025 & 2030
  • REST OF EUROPE
    • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Rest of Europe Historic Review for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 97: Rest of Europe 16-Year Perspective for Pharmaceutical Glass Packaging by Product Type - Percentage Breakdown of Value Sales for Bottles, Vials, Ampoules and Cartridges & Syringes for the Years 2014, 2025 & 2030
    • TABLE 98: Rest of Europe Recent Past, Current & Future Analysis for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Rest of Europe Historic Review for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 100: Rest of Europe 16-Year Perspective for Pharmaceutical Glass Packaging by Drug Type - Percentage Breakdown of Value Sales for Generic, Branded and Biologic for the Years 2014, 2025 & 2030
  • ASIA-PACIFIC
    • Pharmaceutical Glass Packaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • Market Overview
    • Asia-Pacific to Witness Introduction of New Syringes and Ampoules
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Pharmaceutical Glass Packaging by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Pharmaceutical Glass Packaging by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 103: Asia-Pacific 16-Year Perspective for Pharmaceutical Glass Packaging by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 106: Asia-Pacific 16-Year Perspective for Pharmaceutical Glass Packaging by Product Type - Percentage Breakdown of Value Sales for Bottles, Vials, Ampoules and Cartridges & Syringes for the Years 2014, 2025 & 2030
    • TABLE 107: Asia-Pacific Recent Past, Current & Future Analysis for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Asia-Pacific Historic Review for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 109: Asia-Pacific 16-Year Perspective for Pharmaceutical Glass Packaging by Drug Type - Percentage Breakdown of Value Sales for Generic, Branded and Biologic for the Years 2014, 2025 & 2030
  • AUSTRALIA
    • Pharmaceutical Glass Packaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 110: Australia Recent Past, Current & Future Analysis for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Australia Historic Review for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 112: Australia 16-Year Perspective for Pharmaceutical Glass Packaging by Product Type - Percentage Breakdown of Value Sales for Bottles, Vials, Ampoules and Cartridges & Syringes for the Years 2014, 2025 & 2030
    • TABLE 113: Australia Recent Past, Current & Future Analysis for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Australia Historic Review for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 115: Australia 16-Year Perspective for Pharmaceutical Glass Packaging by Drug Type - Percentage Breakdown of Value Sales for Generic, Branded and Biologic for the Years 2014, 2025 & 2030
  • INDIA
    • Pharmaceutical Glass Packaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • Changing Product Portfolio Composition Drives Spending on Packaging
    • TABLE 116: India Recent Past, Current & Future Analysis for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: India Historic Review for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 118: India 16-Year Perspective for Pharmaceutical Glass Packaging by Product Type - Percentage Breakdown of Value Sales for Bottles, Vials, Ampoules and Cartridges & Syringes for the Years 2014, 2025 & 2030
    • TABLE 119: India Recent Past, Current & Future Analysis for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: India Historic Review for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 121: India 16-Year Perspective for Pharmaceutical Glass Packaging by Drug Type - Percentage Breakdown of Value Sales for Generic, Branded and Biologic for the Years 2014, 2025 & 2030
  • SOUTH KOREA
    • TABLE 122: South Korea Recent Past, Current & Future Analysis for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: South Korea Historic Review for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 124: South Korea 16-Year Perspective for Pharmaceutical Glass Packaging by Product Type - Percentage Breakdown of Value Sales for Bottles, Vials, Ampoules and Cartridges & Syringes for the Years 2014, 2025 & 2030
    • TABLE 125: South Korea Recent Past, Current & Future Analysis for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: South Korea Historic Review for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 127: South Korea 16-Year Perspective for Pharmaceutical Glass Packaging by Drug Type - Percentage Breakdown of Value Sales for Generic, Branded and Biologic for the Years 2014, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 128: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Rest of Asia-Pacific Historic Review for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 130: Rest of Asia-Pacific 16-Year Perspective for Pharmaceutical Glass Packaging by Product Type - Percentage Breakdown of Value Sales for Bottles, Vials, Ampoules and Cartridges & Syringes for the Years 2014, 2025 & 2030
    • TABLE 131: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Rest of Asia-Pacific Historic Review for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 133: Rest of Asia-Pacific 16-Year Perspective for Pharmaceutical Glass Packaging by Drug Type - Percentage Breakdown of Value Sales for Generic, Branded and Biologic for the Years 2014, 2025 & 2030
  • LATIN AMERICA
    • Pharmaceutical Glass Packaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • Vials and Ampoules to Witness Robust Demand in Latin America
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Pharmaceutical Glass Packaging by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Pharmaceutical Glass Packaging by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 136: Latin America 16-Year Perspective for Pharmaceutical Glass Packaging by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 139: Latin America 16-Year Perspective for Pharmaceutical Glass Packaging by Product Type - Percentage Breakdown of Value Sales for Bottles, Vials, Ampoules and Cartridges & Syringes for the Years 2014, 2025 & 2030
    • TABLE 140: Latin America Recent Past, Current & Future Analysis for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Latin America Historic Review for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 142: Latin America 16-Year Perspective for Pharmaceutical Glass Packaging by Drug Type - Percentage Breakdown of Value Sales for Generic, Branded and Biologic for the Years 2014, 2025 & 2030
  • ARGENTINA
    • TABLE 143: Argentina Recent Past, Current & Future Analysis for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Argentina Historic Review for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 145: Argentina 16-Year Perspective for Pharmaceutical Glass Packaging by Product Type - Percentage Breakdown of Value Sales for Bottles, Vials, Ampoules and Cartridges & Syringes for the Years 2014, 2025 & 2030
    • TABLE 146: Argentina Recent Past, Current & Future Analysis for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Argentina Historic Review for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 148: Argentina 16-Year Perspective for Pharmaceutical Glass Packaging by Drug Type - Percentage Breakdown of Value Sales for Generic, Branded and Biologic for the Years 2014, 2025 & 2030
  • BRAZIL
    • TABLE 149: Brazil Recent Past, Current & Future Analysis for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Brazil Historic Review for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 151: Brazil 16-Year Perspective for Pharmaceutical Glass Packaging by Product Type - Percentage Breakdown of Value Sales for Bottles, Vials, Ampoules and Cartridges & Syringes for the Years 2014, 2025 & 2030
    • TABLE 152: Brazil Recent Past, Current & Future Analysis for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Brazil Historic Review for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 154: Brazil 16-Year Perspective for Pharmaceutical Glass Packaging by Drug Type - Percentage Breakdown of Value Sales for Generic, Branded and Biologic for the Years 2014, 2025 & 2030
  • MEXICO
    • TABLE 155: Mexico Recent Past, Current & Future Analysis for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Mexico Historic Review for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 157: Mexico 16-Year Perspective for Pharmaceutical Glass Packaging by Product Type - Percentage Breakdown of Value Sales for Bottles, Vials, Ampoules and Cartridges & Syringes for the Years 2014, 2025 & 2030
    • TABLE 158: Mexico Recent Past, Current & Future Analysis for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Mexico Historic Review for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 160: Mexico 16-Year Perspective for Pharmaceutical Glass Packaging by Drug Type - Percentage Breakdown of Value Sales for Generic, Branded and Biologic for the Years 2014, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 161: Rest of Latin America Recent Past, Current & Future Analysis for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Rest of Latin America Historic Review for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 163: Rest of Latin America 16-Year Perspective for Pharmaceutical Glass Packaging by Product Type - Percentage Breakdown of Value Sales for Bottles, Vials, Ampoules and Cartridges & Syringes for the Years 2014, 2025 & 2030
    • TABLE 164: Rest of Latin America Recent Past, Current & Future Analysis for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Rest of Latin America Historic Review for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 166: Rest of Latin America 16-Year Perspective for Pharmaceutical Glass Packaging by Drug Type - Percentage Breakdown of Value Sales for Generic, Branded and Biologic for the Years 2014, 2025 & 2030
  • MIDDLE EAST
    • Pharmaceutical Glass Packaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Pharmaceutical Glass Packaging by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Pharmaceutical Glass Packaging by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 169: Middle East 16-Year Perspective for Pharmaceutical Glass Packaging by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 172: Middle East 16-Year Perspective for Pharmaceutical Glass Packaging by Product Type - Percentage Breakdown of Value Sales for Bottles, Vials, Ampoules and Cartridges & Syringes for the Years 2014, 2025 & 2030
    • TABLE 173: Middle East Recent Past, Current & Future Analysis for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Middle East Historic Review for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 175: Middle East 16-Year Perspective for Pharmaceutical Glass Packaging by Drug Type - Percentage Breakdown of Value Sales for Generic, Branded and Biologic for the Years 2014, 2025 & 2030
  • IRAN
    • TABLE 176: Iran Recent Past, Current & Future Analysis for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Iran Historic Review for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 178: Iran 16-Year Perspective for Pharmaceutical Glass Packaging by Product Type - Percentage Breakdown of Value Sales for Bottles, Vials, Ampoules and Cartridges & Syringes for the Years 2014, 2025 & 2030
    • TABLE 179: Iran Recent Past, Current & Future Analysis for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Iran Historic Review for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 181: Iran 16-Year Perspective for Pharmaceutical Glass Packaging by Drug Type - Percentage Breakdown of Value Sales for Generic, Branded and Biologic for the Years 2014, 2025 & 2030
  • ISRAEL
    • TABLE 182: Israel Recent Past, Current & Future Analysis for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Israel Historic Review for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 184: Israel 16-Year Perspective for Pharmaceutical Glass Packaging by Product Type - Percentage Breakdown of Value Sales for Bottles, Vials, Ampoules and Cartridges & Syringes for the Years 2014, 2025 & 2030
    • TABLE 185: Israel Recent Past, Current & Future Analysis for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Israel Historic Review for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 187: Israel 16-Year Perspective for Pharmaceutical Glass Packaging by Drug Type - Percentage Breakdown of Value Sales for Generic, Branded and Biologic for the Years 2014, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 188: Saudi Arabia Recent Past, Current & Future Analysis for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Saudi Arabia Historic Review for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 190: Saudi Arabia 16-Year Perspective for Pharmaceutical Glass Packaging by Product Type - Percentage Breakdown of Value Sales for Bottles, Vials, Ampoules and Cartridges & Syringes for the Years 2014, 2025 & 2030
    • TABLE 191: Saudi Arabia Recent Past, Current & Future Analysis for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Saudi Arabia Historic Review for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 193: Saudi Arabia 16-Year Perspective for Pharmaceutical Glass Packaging by Drug Type - Percentage Breakdown of Value Sales for Generic, Branded and Biologic for the Years 2014, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 194: UAE Recent Past, Current & Future Analysis for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 195: UAE Historic Review for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 196: UAE 16-Year Perspective for Pharmaceutical Glass Packaging by Product Type - Percentage Breakdown of Value Sales for Bottles, Vials, Ampoules and Cartridges & Syringes for the Years 2014, 2025 & 2030
    • TABLE 197: UAE Recent Past, Current & Future Analysis for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 198: UAE Historic Review for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 199: UAE 16-Year Perspective for Pharmaceutical Glass Packaging by Drug Type - Percentage Breakdown of Value Sales for Generic, Branded and Biologic for the Years 2014, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 200: Rest of Middle East Recent Past, Current & Future Analysis for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Rest of Middle East Historic Review for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 202: Rest of Middle East 16-Year Perspective for Pharmaceutical Glass Packaging by Product Type - Percentage Breakdown of Value Sales for Bottles, Vials, Ampoules and Cartridges & Syringes for the Years 2014, 2025 & 2030
    • TABLE 203: Rest of Middle East Recent Past, Current & Future Analysis for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Rest of Middle East Historic Review for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 205: Rest of Middle East 16-Year Perspective for Pharmaceutical Glass Packaging by Drug Type - Percentage Breakdown of Value Sales for Generic, Branded and Biologic for the Years 2014, 2025 & 2030
  • AFRICA
    • Pharmaceutical Glass Packaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 206: Africa Recent Past, Current & Future Analysis for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Africa Historic Review for Pharmaceutical Glass Packaging by Product Type - Bottles, Vials, Ampoules and Cartridges & Syringes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 208: Africa 16-Year Perspective for Pharmaceutical Glass Packaging by Product Type - Percentage Breakdown of Value Sales for Bottles, Vials, Ampoules and Cartridges & Syringes for the Years 2014, 2025 & 2030
    • TABLE 209: Africa Recent Past, Current & Future Analysis for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Africa Historic Review for Pharmaceutical Glass Packaging by Drug Type - Generic, Branded and Biologic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 211: Africa 16-Year Perspective for Pharmaceutical Glass Packaging by Drug Type - Percentage Breakdown of Value Sales for Generic, Branded and Biologic for the Years 2014, 2025 & 2030

IV. COMPETITION